Our Services
Medical Information
Helpful Resources
Published on: 6/15/2026
Hypermobile Ehlers-Danlos syndrome (hEDS) is a connective tissue disorder caused by altered collagen, resulting in overly lax joints, chronic pain, persistent fatigue and frequent joint instability that can significantly disrupt daily function.
Symptom severity in hEDS is shaped by several overlapping factors, including mechanical joint stress, central sensitization, autonomic dysfunction (such as POTS) and proprioceptive deficits. Effective management typically requires accurate diagnosis, multidisciplinary care and targeted lifestyle strategies—each detailed below.
Because hEDS symptoms overlap with many other conditions, identifying what's actually driving your pain, fatigue or instability is the critical first step toward relief. A free, instant, online symptom check can help you clarify your symptoms, understand possible causes and confidently navigate your next steps—whether that's seeing a specialist, requesting specific tests or starting evidence-based self-care.
Reviewed for medical accuracy: 06/15/2026
Hypermobile Ehlers-Danlos syndrome (hEDS) is a genetic connective tissue disorder marked by unusually flexible joints, stretchy skin, and tissue fragility. While flexibility might sound like an advantage, in hEDS it often leads to chronic pain, fatigue, and joint instability. This guide explains why.
In hEDS, the body's collagen—an essential protein that gives structure to skin, ligaments, and tendons—is altered. This affects stability in several ways:
Ligament Laxity
Over-elastic ligaments can't support joints properly. This leads to:
Muscle Overuse
Muscles work harder to compensate for loose ligaments, causing:
Joint Misalignment
Loose connective tissue allows joints to move beyond their normal range. Over time, this results in:
Pain in hypermobility Ehlers-Danlos stems from multiple sources:
Key Point: Effective pain management may require both physical and neurological approaches, such as low-impact therapy plus medications or nerve modulation techniques.
People with hypermobility Ehlers-Danlos often report relentless tiredness. Contributing factors include:
Joint instability in hEDS can lead to:
Beyond joints and pain, hEDS can affect multiple systems:
Diagnosis is clinical, based on the 2017 International EDS Consortium criteria:
Genetic testing for hEDS is not yet definitive, making a thorough clinical evaluation essential.
While there's no cure for hypermobility Ehlers-Danlos, targeted treatments can improve quality of life:
A team approach can include:
Always speak to a doctor if you experience:
For non-urgent concerns, your primary care provider or a specialist familiar with hypermobility Ehlers-Danlos can guide you.
Remember, if you're concerned about visual disturbances like Eye floaters, a quick online assessment can help you determine next steps for eye care. And as always, discuss any concerning or life-threatening symptoms with your doctor promptly.
(References)
* Malfait F, Francomano R, Byers P, Belmont B, Berglund B, Børresen-Dale AL, Dean J, De Paepe A, De Schepper S, De Vos M, Fasshauer I, Freire M, Glushko T, Grahame R, Gravholt CH, Hamans E, Hazewinkel M, Heiberg A, Henderson E, Hendry R, Holm AA, Houweling A, Hulshoff L, Janssens K, Kampschreur P, Loeys B, Malfait V, Martens K, Martens P, Miller V, Monnier B, Monstad S, Mortier G, Muley R, Nuytinck L, O'Neill M, Oostra A, Otten E, Pacey J, Paepe A, Peeters N, Pillay K, Puschmann L, Raas C, Rasmussen L, Reardon W, Richter R, Rohrbach M, Rosser T, Rombaut L, Ruys B, Salter A, Sanders C, Schrander-Stumpel C, Sedky R, Simmonds J, Sørhaug A, Steinmann B, Stewart S, Toudjarska G, Van Dijk F, Van Gompel P, Van Hoof L, Van Overbeeke E, Van Zandbergen B, Vervaele P, Vlaminck H, Volpe P, Weitz S, Wikler L, Wierzbicka-Winiarska K. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26. doi: 10.1002/ajmg.c.31552. PMID: 28383274.
* Ali A, Al-Bayaty Z, Al-Jayyousi H, Allwood C, Alshingiti H, Alshingiti A, Al-Shingiti A, Ali A. Pain in the Ehlers-Danlos Syndromes: a systematic review. J Pain Res. 2020 Jan 24;13:217-241. doi: 10.2147/JPR.S228043. PMID: 32017366; PMCID: PMC6990423.
* Hakim A, O'Sullivan M, Barwise-Cook T, Patel M, Davies F, O'Connor V, Chopra P, Patel M. Fatigue in hypermobile Ehlers-Danlos syndrome: An overview of assessment and management. Am J Med Genet C Semin Med Genet. 2021 Sep;187(3):362-371. doi: 10.1002/ajmg.c.31934. Epub 2021 Jul 1. PMID: 34199859.
* Chopra P, Patel M, Hakim A. Hypermobile Ehlers-Danlos Syndrome: A Review of the Current Understanding of Management Strategies. Pain Ther. 2021 Dec;10(2):833-846. doi: 10.1007/s40122-021-00281-2. Epub 2021 Aug 7. PMID: 34360982; PMCID: PMC8670868.
* Pacey J, Graham R, Butler J. Joint hypermobility and the Ehlers-Danlos syndromes: A genetic, clinical, and biochemical perspective. Connect Tissue Res. 2021 Nov;62(6):531-542. doi: 10.1080/00408166.2021.1998818. Epub 2021 Nov 1. PMID: 34726590.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.